International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
Crossref
1. Predictive Value of Machine Learning Models in Mortality of Coronavirus Disease 2019 (COVID-19) Pneumonia
- Atefeh Rostami
- Faezeh Mousavi
- Seyed Alireza Javadinia
- Mostafa Robatjazi
- Mohammad Mehrpouyan
2. A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?
- Maryam Joudi
- Maryam Moradi Binabaj
- Pejman Porouhan
- Babak PeyroShabany
- Mohsen Tabasi
- Danial Fazilat-Panah
- Mahtab Khajeh
- Arezoo Mehrabian
- Mansoureh Dehghani
- James S. Welsh
- Batol Keykhosravi
- Azam Akbari Yazdi
- Mona Ariamanesh
- Ahmad Ghasemi
- Gordon Ferns
- Seyed Alireza Javadinia
3. Psychosomatic Symptoms in Terminally Ill Cancer Patients and Its Relation With Using Complementary and Alternative Medicines: A Cross-Sectional Study in Southeast Iran
- Mahlagha Dehghan
- Fatemeh Sadat Hoseini
- Mohammad Ali Zakeri
4. Efficacy of Sinopharm Vaccine Among Stem Cell Transplant Recipients During Two Peaks of Delta and Omicron variants of COVID-19
- Ali Ghasemi
- Rozita Khodashahi
- Mohsen Aliakbarian
- Ebrahim Khaleghi
- Baran Razmkhah
- Mehrsa Vahdatinia
- Mahdi Salimi Far
- Omolbanin Bakhti
5. Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study
- Kyoungmin Lee
- In Hae Park
- Sang Cheul Oh
- Jae Hong Seo
- Min Ji Jeon
- Eun Sang Yu
- Dae Sik Kim
- Chul Won Choi
- Ah‐reum Lim
- Myung Han Hyun
- Ju Won Kim
- Jwa Hoon Kim
- Yoon Ji Choi
- Soohyeon Lee
- Kyong Hwa Park
- Yeul Hong Kim
- Jung Yoon Choi
- Jung Sun Kim
- Se Ryeon Lee
- Hwa Jung Sung
- Eun Joo Kang
6. Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer
- Yuling Han
- Jiaxin Yang
- Danshuang He
- Yang Feng
- Xiaoman Liu
- Yu Min
- Shenghao Fan
- Guobing Yin
- Daixing Hu
7. Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer
- Rui Song
- Li Liu
- Qingbo Pan
- Jin Liu
- Jiahe Tan
- Juan Deng
- Qin Deng
- Zijin Lin
- Min Chen
- Mingli Peng
- Hong Ren
- Jia Ming
8. Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 Pandemic
- Seyed Alireza Javadinia
- Mona Ariamanesh
- Maryam Nabavifard
- Pejman Porouhan
- Babak PeyroShabany
- Danial Fazilat-Panah
- Farbod Hatami
- Ahmad Ghasemi
- Gary H. Lyman
- James S. Welsh
- Somayeh Ashkar Tizabi
- Mansoureh Dehghani
9. COVID-19 Breakthrough Infections Among Patients with Cancer Receiving Sinopharm BBIBP-CorV Vaccine
- Amirreza Manteghinejad
- Saeedeh Arabzadeh
- Zahra Rezaian
- Mehran Sharifi
- Shaghayegh Haghjooy Javanmard
10. Hospital and post-discharge mortality in COVID-19 patients with a preexisting cancer diagnosis in Iran
- Monireh Sadat Seyyedsalehi
- Marveh Rahmati
- Reza Ghalehtaki
- Azin Nahvijou
- Bita Eslami
- Zoha Shaka
- Seyed Farshad Allameh
- Kazem Zendehdel
11. Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy
- Mona Ariamanesh
- Pejman Porouhan
- Babak PeyroShabany
- Danial Fazilat-Panah
- Mansoureh Dehghani
- Maryam Nabavifard
- Farbod Hatami
- Mohammad Fereidouni
- James S. Welsh
- Seyed Alireza Javadinia
12. Evaluation of Nutritional Status and Anxiety Levels in Patients Applying to the Radiation Oncology Outpatient Clinic during the COVID-19 Pandemic: Turkish Society for Radiation Oncology Group Study (TROD 12:02)
- Vuslat Yurut Caloglu
- Muge Akmansu
- Deniz Yalman
- Sule Karabulut Gul
- Zafer Kocak
- Zumre Arican Alicikus
- Alparslan Serarslan
- Serap Akyurek
- Teuta Zoto Mustafayev
- Candan Demiroz
- Didem Colpan Oksuz
- Gul Kanyilmaz
- Pelin Altinok
- Esra Kaytan Saglam
- Ayben Yentek Balkanay
- Halil Akboru
- Emine Keven
- Berna Yildirim
- Cem Onal
- Sefik Igdem
- Emre Ozkan
- Fatih Ozdener
- Murat Caloglu
13. Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
- Jingjing Lv
- Hui Wu
- Junjie Xu
- Jiaye Liu
14. Massive pericardial effusion as the first manifestation of childhood non‐Hodgkin's lymphoma: A case report
- Behzad Alizadeh
- Zahra Shaye
- Zahra Badiea
- Paria Dehghanian
15. A year of experience with COVID‐19 in patients with cancer: A nationwide study
- Mina Khosravifar
- Sogol Koolaji
- Negar Rezaei
- Ali Ghanbari
- Seyedeh Melika Hashemi
- Erfan Ghasemi
- Ali Bitaraf
- Ozra Tabatabaei‐Malazy
- Nazila Rezaei
- Sahar Mohammadi Fateh
- Arezou Dilmaghani‐Marand
- Rosa Haghshenas
- Ameneh Kazemi
- Erfan Pakatchian
- Farzad Kompani
- Shirin Djalalinia
16. Convenient Access to Expert-Reviewed Health Information via an Alexa Voice Assistant Skill for Patients With Multiple Myeloma: Development Study
- Marc-Andrea Baertsch
- Sarah Decker
- Leona Probst
- Stefan Joneleit
- Hans Salwender
- Franziska Frommann
- Hartwig Buettner
17. Clinical characteristics, risk factors and outcomes of cancer patients withCOVID‐19: A population‐based study
- Jiandong Zhou
- Ishan Lakhani
- Oscar Chou
- Keith Sai Kit Leung
- Teddy Tai Loy Lee
- Michelle Vangi Wong
- Zhen Li
- Abraham Ka Chung Wai
- Carlin Chang
- Ian Chi Kei Wong
- Qingpeng Zhang
- Gary Tse
- Bernard Man Yung Cheung
18. Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis
- Juntao Yin
- Yangyang Chen
- Yang Li
- Xingwang Zhang
- Chaoyang Wang
19. Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer
- Tong Li
- Rui Song
- Jingjie Wang
- Jianbo Zhang
- Hongxing Cai
- Hongmei He
- Wei Hu
- Dajun Yu
- Chuanhu Wang
- Qingbo Pan
- Mingli Peng
- Hong Ren
- Peng Zhu
20. Experiences of cancer care in COVID-19: A longitudinal qualitative study
- Maura Dowling
- Manuela Eicher
- Amanda Drury
21. COVID-19 mortality and risk factors in patients with cancer in Ecuador: A retrospective, non-randomized, controlled study
- Evelyn Valencia-Espinoza
- María del Carmen Cabezas
- Andrea Plaza
- Katherine García
- Carlos Calle
- Marco Fornasini
- José Luna
- Camila Miño
22. Challenges posed by COVID‐19 in cancer patients: A narrative review
- Zeinab Mohseni Afshar
- Rezvan Hosseinzadeh
- Mohammad Barary
- Soheil Ebrahimpour
- Amirmasoud Alijanpour
- Babak Sayad
- Dariush Hosseinzadeh
- Seyed Rouhollah Miri
- Terence T. Sio
- Mark J. M. Sullman
- Kristin Carson‐Chahhoud
- Arefeh Babazadeh
23. Clinical characteristics and outcomes of lung cancer patients with COVID-19: A systematic review and meta-analysis protocol
- Mingyue Wu
- Siru Liu
- Yi Yang
- Jie Lin
- Jialin Liu
- Muhammad Shahzad Aslam
24. COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety
- Seyed Alireza Javadinia
- Kimia Alizadeh
- Mohammad-Shafi Mojadadi
- Fateme Nikbakht
- Farzaneh Dashti
- Maryam Joudi
- Hadi Harati
- James S. Welsh
- Seyed Amir Farahmand
- Fahimeh Attarian
25. Clinical Characteristics and Outcomes of COVID-19 in 1294 New Cancer Patients: Single-Center, Prospective Cohort Study from Iran
- Danial Fazilat-Panah
- Hamid Fallah Tafti
- Yavar Rajabzadeh
- Maedeh Alsadat Fatemi
- Nahid Ahmadi
- Davoud Jahansouz
- Mohsen Tabasi
- Seyed Alireza Javadinia
- Maryam Joudi
- Hadi Harati
- Fahimeh Attarian
- Farzad Taghizadeh-Hesary
26. Antigen rapid diagnostic test monitoring for SARS‐CoV‐2 in asymptomatic and fully vaccinated cancer patients: Is it cost‐effective?
- Mario Caccese
- Anna Maria Saieva
- Valentina Guarneri
- Sara Lonardi
- Massimo Cacco
- Vanna Chiarion Sileni
- Michele Gottardi
- Eleonora Mioranza
- Francesca Bergamo
- Antonella Brunello
- Vittorina Zagonel
- Patrizia Benini
27. COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status
- Zhujun Cao
- Chenxi Zhang
- Shuang Zhao
- Zike Sheng
- Xiaogang Xiang
- Ruokun Li
- Zhuping Qian
- Yinling Wang
- Bin Chen
- Ziqiang Li
- Yuhan Liu
- Baoyan An
- Huijuan Zhou
- Wei Cai
- Hui Wang
- Honglian Gui
- Haiguang Xin
- Qing Xie
28. Comparing the COVID-19 Mortality Rate in Cancer Patients with and Without a History of Chemotherapy
- Nasrin Bazgir
- Fakhredin Taghinezhad
- Hassan Nourmohammadi
- Golnaz Azami
- Iraj Ahmadi
- Aliashraf Mozafari
29. Research trends and hotspots of breast cancer management during the COVID-19 pandemic: A bibliometric analysis
- Peng-fei Lyu
- Jing-tai Li
- Tang Deng
- Guang-Xun Lin
- Ping-ming Fan
- Xu-Chen Cao
30. Clinical characteristics of COVID-19-infected cancer patients, Isfahan, Iran
- Mehran Sharifi
- Golnaz Vaseghi
- Maryam Nasirian
- Saeedeh Arabzadeh
- Marjan Pourhadi
- Somayeh Hajiahmadi
- Laleh Shariati
- Shaghayegh Haghjooy Javanmard
31. COVID-19 disease severity and associated factors among Ethiopian patients: A study of the millennium COVID-19 care center
- Tigist W. Leulseged
- Kindalem G. Abebe
- Ishmael S. Hassen
- Endalkachew H. Maru
- Wuletaw C. Zewde
- Negat W. Chamiso
- Kalkidan T. Yegele
- Abdi B. Bayisa
- Dagne F. Siyoum
- Mesay G. Edo
- Edmialem G. Mesfin
- Meskerem N. Derejie
- Helina K. Shiferaw
- Farzad Taghizadeh-Hesary
32. SARS-CoV-2 antibody response after BBIBP-CorV (Sinopharm) vaccination in cancer patients: A case-control study
- Fahimeh Safarnezhad Tameshkel
- Shabnam Abedin Dargoush
- Bahareh Amirkalali
- Saeedeh Javadi
- Ali Ghiaseddin
- Yousef Alimohamadi
- Ali Basi
- Mahin Jamshidi Makiani
- Farhad Zamani
- Mohammad Hadi Karbalaie Niya
33. A case report of mediastinal cavernous hemangioma
- Davoud Ouladdameshghi
- Mohsen Eshraghi
- Alireza Shahhamzeh
- Mohammad Mehdi Riyah
- Maedeh Alsadat Fatemi
- Danial Fazilat‐Panah
- Mansoureh Dehghani
34. Outcomes of COVID-19 in immunocompromised patients: a single center experience
- Masoud Mardani
- Jafar Mohammadshahi
- Roghayeh Teimourpour